{"id":27415,"date":"2025-05-06T15:43:18","date_gmt":"2025-05-06T22:43:18","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27415"},"modified":"2025-05-06T15:46:17","modified_gmt":"2025-05-06T22:46:17","slug":"ivig-for-bk-virus-associated-nephropathy-bkvn","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/","title":{"rendered":"IgIV para la nefropat\u00eda asociada al virus BK (BKVN)"},"content":{"rendered":"<p>Las personas que han recibido un trasplante de ri\u00f1\u00f3n suelen desarrollar una afecci\u00f3n llamada nefropat\u00eda asociada al virus BK (o NVBK). Se trata de un problema renal grave causado por el virus BK. Si no se trata adecuadamente, puede contribuir a la insuficiencia renal o a la p\u00e9rdida prematura del injerto en los receptores de un trasplante de ri\u00f1\u00f3n (personas que recibieron un ri\u00f1\u00f3n sano de un donante).&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-e038f720ecaa0d587d4036a4641547e8\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tPregunte sobre la infusi\u00f3n de IgIV en el hogar\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Actualmente, no existe una terapia est\u00e1ndar para el manejo de la BKVN. La \u00fanica opci\u00f3n es reducir la dosis de inmunosupresi\u00f3n, lo cual no siempre es posible ni eficaz en ciertos pacientes.&nbsp;<\/p>\n\n\n\n<p>Sin embargo, el uso <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\">IgIV<\/a> Puede ayudar a controlar la nefropat\u00eda asociada al virus BK. Contin\u00fae leyendo para saber c\u00f3mo funciona la terapia con IgIV.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#BK_Virus-Associated_Nephropathy_Basic_Overview\" >Nefropat\u00eda asociada al virus BK: descripci\u00f3n general b\u00e1sica<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#Standard_Treatments_for_BK_Virus-Associated_Nephropathy\" >Tratamientos est\u00e1ndar para la nefropat\u00eda asociada al virus BK<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#IVIG_for_BK_Virus-Associated_Nephropathy_BKVN_Research_Evidence\" >IgIV para la nefropat\u00eda asociada al virus BK (BKVN): evidencia cient\u00edfica<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#Efficacy_of_IVIG_in_Combination_With_Other_Drugs\" >Eficacia de la IgIV en combinaci\u00f3n con otros f\u00e1rmacos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#How_Does_IVIG_Manage_BK_Virus-Associated_Nephropathy_BKVN\" >\u00bfC\u00f3mo controla la IgIV la nefropat\u00eda asociada al virus BK (BKVN)?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#1_Direct_Neutralization\" >1. Neutralizaci\u00f3n directa<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#2_Immune_System_Modulation\" >2. Modulaci\u00f3n del sistema inmunitario<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#When_Is_IVIG_Used\" >\u00bfCu\u00e1ndo se utiliza IgIV?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#IVIG_Administration_and_Side_Effects\" >Administraci\u00f3n de IgIV y efectos secundarios<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#The_Bottom_Line\" >El resultado final<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-bk-virus-associated-nephropathy-basic-overview\"><span class=\"ez-toc-section\" id=\"BK_Virus-Associated_Nephropathy_Basic_Overview\"><\/span><strong>Nefropat\u00eda asociada al virus BK: descripci\u00f3n general b\u00e1sica<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La mayor\u00eda de las personas se exponen al virus BK durante la infancia, y este suele permanecer inactivo (latente) en el ri\u00f1\u00f3n y el tracto urinario. En estado latente, el virus BK no causa ning\u00fan problema.&nbsp;<\/p>\n\n\n\n<p>Sin embargo, el virus BK se reactiva (se activa) en los receptores de trasplante de ri\u00f1\u00f3n cuando toman inmunosupresores (o agentes antirrechazo) para prevenir el rechazo del \u00f3rgano. Desafortunadamente, estos medicamentos tambi\u00e9n debilitan el sistema inmunitario, lo que crea un entorno ideal para que el virus se multiplique e infecte las c\u00e9lulas renales trasplantadas.&nbsp;<\/p>\n\n\n\n<p>La infecci\u00f3n provoca inflamaci\u00f3n y da\u00f1o a los tejidos renales (nefropat\u00eda), lo que conduce a una disminuci\u00f3n de la funci\u00f3n del ri\u00f1\u00f3n trasplantado y, eventualmente, progresa a una falla del injerto.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-standard-treatments-for-bk-virus-associated-nephropathy\"><span class=\"ez-toc-section\" id=\"Standard_Treatments_for_BK_Virus-Associated_Nephropathy\"><\/span><strong>Tratamientos est\u00e1ndar para la nefropat\u00eda asociada al virus BK<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El tratamiento est\u00e1ndar para el virus BKN consiste en reducir la dosis de inmunosupresores para que el sistema inmunitario del paciente combata el virus BK con mayor eficacia. Sin embargo, esta estrategia presenta ciertas dificultades, ya que puede aumentar el riesgo de rechazo del trasplante. Adem\u00e1s, en algunos casos, esta estrategia terap\u00e9utica resulta ineficaz en ciertos pacientes.&nbsp;<\/p>\n\n\n\n<p>Los investigadores ahora est\u00e1n explorando tratamientos alternativos, como la IgIV, para controlar el BKVN en los receptores de trasplantes de ri\u00f1\u00f3n.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ivig-for-bk-virus-associated-nephropathy-bkvn-research-evidence\"><span class=\"ez-toc-section\" id=\"IVIG_for_BK_Virus-Associated_Nephropathy_BKVN_Research_Evidence\"><\/span><strong>IgIV para la nefropat\u00eda asociada al virus BK (BKVN): evidencia cient\u00edfica<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"285\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse.jpg\" alt=\"Nurse preparing IVIG for BK Virus-Associated Nephropathy (BKVN)\" class=\"wp-image-27418\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse-300x204.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse-86x58.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse-167x113.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse-280x190.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/ivig-nurse-370x251.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Aunque la investigaci\u00f3n sobre el tratamiento con IgIV para la BKVN est\u00e1 en curso, varios estudios cl\u00ednicos peque\u00f1os e informes de casos han reportado resultados prometedores. Por ejemplo, un <a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)00987-7\/fulltext\">estudio retrospectivo de un solo centro<\/a> publicado en la Revista de Trasplante Renal e Inmunolog\u00eda de Trasplantes<em> <\/em>Se inform\u00f3 que la IgIV elimina eficazmente el virus BK y mantiene la funci\u00f3n normal del injerto en los receptores de trasplantes de ri\u00f1\u00f3n pedi\u00e1tricos.&nbsp;<\/p>\n\n\n\n<p>De manera similar, una <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38777712\/\">informe de caso<\/a> Un estudio publicado en 2024 revel\u00f3 que la IgIV puede tratar eficazmente la BKVN cuando el tratamiento est\u00e1ndar fracasa. Un paciente de 37 a\u00f1os con trasplante renal no mostr\u00f3 mejor\u00eda tras reducir la dosis de inmunosupresores, pero tras dos dosis de IgIV, su carga viral disminuy\u00f3 de m\u00e1s de 2 millones a 5500 copias\/ml. Esto sugiere que la IgIV podr\u00eda ser una opci\u00f3n de segunda l\u00ednea \u00fatil para el tratamiento de la BKVN.<\/p>\n\n\n\n<p>Otro <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7549878\/\">estudiar<\/a> Se inform\u00f3 que la IgIV es un tratamiento prometedor para mejorar la gravedad de BKVN, especialmente en casos en los que se encontr\u00f3 que una reducci\u00f3n de la dosis de inmunosupresores era efectiva.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-efficacy-of-ivig-in-combination-with-other-drugs\"><span class=\"ez-toc-section\" id=\"Efficacy_of_IVIG_in_Combination_With_Other_Drugs\"><\/span>Eficacia de la IgIV en combinaci\u00f3n con otros f\u00e1rmacos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Tambi\u00e9n se han realizado investigaciones para estudiar el impacto de la inmunoglobulina intravenosa (IVIG) en combinaci\u00f3n con otros medicamentos en receptores de trasplante de ri\u00f1\u00f3n. Por ejemplo, un <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0041134515000883\">estudiar<\/a> publicado en el<em> <\/em>Revista de procedimientos sobre trasplantes<em> <\/em>se inform\u00f3 que una dosis alta de IgIV (1 g\/kg) combinada con leflunomida disminuy\u00f3 significativamente la carga viral de BK dentro de 1 mes de tratamiento.&nbsp;<\/p>\n\n\n\n<p>De la misma manera, otro <a href=\"https:\/\/journals.lww.com\/transplantationdirect\/fulltext\/2017\/04000\/clearance_of_bk_virus_nephropathy_by_combination.3.aspx\">estudiar<\/a> Un estudio que incluy\u00f3 a 50 pacientes con BKVN mostr\u00f3 que 1 g\/kg de IgIV adem\u00e1s del ajuste de la inmunosupresi\u00f3n parece ser m\u00e1s eficaz para eliminar el virus BK de la sangre y del tejido del trasplante renal.<\/p>\n\n\n\n<p>En otras palabras, la IgIV sola o combinada con el tratamiento tradicional ha demostrado ser eficaz para mejorar la funci\u00f3n renal y reducir el nivel de virus BK en los receptores.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-76d8daca64ae082b9f1ac31783b027ff\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsulte a un especialista en IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">M\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-ivig-manage-bk-virus-associated-nephropathy-bkvn\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Manage_BK_Virus-Associated_Nephropathy_BKVN\"><\/span><strong>\u00bfC\u00f3mo controla la IgIV la nefropat\u00eda asociada al virus BK (BKVN)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La terapia con IgIV, que proporciona a los pacientes <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/immunoglobulins-ig\/\">anticuerpos<\/a>Se cree que gestiona BKVN de dos maneras:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-direct-neutralization\"><span class=\"ez-toc-section\" id=\"1_Direct_Neutralization\"><\/span>1. <strong>Neutralizaci\u00f3n directa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los anticuerpos (IgG) proporcionados por la terapia con IgIV pueden contrarrestar las diferentes cepas del virus BK. Cuando los anticuerpos IgG se unen al virus BK, impiden que este infecte las c\u00e9lulas renales.&nbsp;<\/p>\n\n\n\n<p>De hecho, un <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1600613522001757\">estudio experimental<\/a> Se inform\u00f3 que la IG disponible comercialmente contiene potentes anticuerpos neutralizantes, que son capaces de neutralizar todos los genotipos principales de BKV.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-immune-system-modulation\"><span class=\"ez-toc-section\" id=\"2_Immune_System_Modulation\"><\/span>2. <strong>Modulaci\u00f3n del sistema inmunitario<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Se cree que la IgIV puede modular el sistema inmunitario al potenciar la respuesta antiviral del organismo. Esto tambi\u00e9n ayuda a reducir la inflamaci\u00f3n renal y previene un mayor da\u00f1o tisular.&nbsp;<\/p>\n\n\n\n<p>Una ventaja importante de la IgIV es que su doble acci\u00f3n puede controlar la replicaci\u00f3n del virus sin aumentar el riesgo de rechazo del trasplante.&nbsp;<\/p>\n\n\n\n<p><strong>Nota:<\/strong> La IgIV no es una cura, sino que solo se utiliza como terapia complementaria para tratar la nefropat\u00eda asociada al virus BK.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-when-is-ivig-used\"><span class=\"ez-toc-section\" id=\"When_Is_IVIG_Used\"><\/span><strong>\u00bfCu\u00e1ndo se utiliza IgIV?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los proveedores de atenci\u00f3n m\u00e9dica generalmente consideran el tratamiento con IgIV cuando la carga viral de BK aumenta en la orina y la sangre del paciente, y su funci\u00f3n renal comienza a empeorar incluso despu\u00e9s de reducir la dosis de medicamentos inmunosupresores.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ivig-administration-and-side-effects\"><span class=\"ez-toc-section\" id=\"IVIG_Administration_and_Side_Effects\"><\/span><strong>Administraci\u00f3n de IgIV y efectos secundarios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV suele administrarse por infusi\u00f3n intravenosa lenta durante varias horas en un hospital o cl\u00ednica. La frecuencia de las dosis de IgIV puede variar entre los receptores de trasplante renal.&nbsp;<\/p>\n\n\n\n<p>Si est\u00e1 recibiendo tratamiento con IgIV, es posible que experimente algunos efectos secundarios leves como: <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-headaches\/\">dolores de cabeza<\/a>Escalofr\u00edos y fatiga. Su profesional de la salud podr\u00eda incluso recetarle premedicamentos para tomar antes de su dosis de IgIV para ayudar a prevenir reacciones o efectos secundarios relacionados con la infusi\u00f3n. Estos efectos secundarios son temporales y se resuelven en poco tiempo. Adem\u00e1s, rara vez se presentan efectos graves, como reacciones al\u00e9rgicas o formaci\u00f3n de co\u00e1gulos sangu\u00edneos.<\/p>\n\n\n\n<p>Le recomendamos que consulte a su proveedor de atenci\u00f3n m\u00e9dica inmediatamente si experimenta alguno de los efectos secundarios mencionados anteriormente.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-the-bottom-line\"><span class=\"ez-toc-section\" id=\"The_Bottom_Line\"><\/span><strong>El resultado final<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La nefropat\u00eda asociada al virus BK representa una amenaza significativa para los receptores de trasplante renal. Sin embargo, la detecci\u00f3n temprana y el tratamiento oportuno pueden ayudar a prevenir esta infecci\u00f3n y mejorar la tasa de \u00e9xito del trasplante en personas que reciben este tipo de trasplante.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Las personas que han recibido un trasplante de ri\u00f1\u00f3n suelen desarrollar una afecci\u00f3n llamada nefropat\u00eda asociada al virus BK (o NVBK). Se trata de un problema renal grave causado por el virus BK. Si no se trata adecuadamente, puede contribuir a la insuficiencia renal o a la p\u00e9rdida prematura del injerto en los receptores de un trasplante de ri\u00f1\u00f3n (personas que recibieron un ri\u00f1\u00f3n sano de un donante).\u00a0<\/p>","protected":false},"author":26,"featured_media":27416,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[32],"class_list":["post-27415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for BK Virus-Associated Nephropathy (BKVN)<\/title>\n<meta name=\"description\" content=\"Learn about IVIG for BK Virus-Associated Nephropathy. Topics include an overview of BKVN, research evidence, how IVIG manages BKVN, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for BK Virus-Associated Nephropathy (BKVN)\" \/>\n<meta property=\"og:description\" content=\"Learn about IVIG for BK Virus-Associated Nephropathy. Topics include an overview of BKVN, research evidence, how IVIG manages BKVN, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-06T22:43:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-06T22:46:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"IVIG for BK Virus-Associated Nephropathy (BKVN)\",\"datePublished\":\"2025-05-06T22:43:18+00:00\",\"dateModified\":\"2025-05-06T22:46:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/\"},\"wordCount\":948,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/doctor-model-kidney.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/\",\"name\":\"IVIG for BK Virus-Associated Nephropathy (BKVN)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/doctor-model-kidney.jpg\",\"datePublished\":\"2025-05-06T22:43:18+00:00\",\"dateModified\":\"2025-05-06T22:46:17+00:00\",\"description\":\"Learn about IVIG for BK Virus-Associated Nephropathy. Topics include an overview of BKVN, research evidence, how IVIG manages BKVN, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/doctor-model-kidney.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/doctor-model-kidney.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor with an anatomical model of a human kidney\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-bk-virus-associated-nephropathy-bkvn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for BK Virus-Associated Nephropathy (BKVN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para la nefropat\u00eda asociada al virus BK (BKVN)","description":"Aprenda sobre la IgIV para la nefropat\u00eda asociada al virus BK. Los temas incluyen una descripci\u00f3n general de la nefropat\u00eda asociada al virus BK, evidencia cient\u00edfica, c\u00f3mo la IgIV la trata y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for BK Virus-Associated Nephropathy (BKVN)","og_description":"Learn about IVIG for BK Virus-Associated Nephropathy. Topics include an overview of BKVN, research evidence, how IVIG manages BKVN, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-05-06T22:43:18+00:00","article_modified_time":"2025-05-06T22:46:17+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"IVIG for BK Virus-Associated Nephropathy (BKVN)","datePublished":"2025-05-06T22:43:18+00:00","dateModified":"2025-05-06T22:46:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/"},"wordCount":948,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/","url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/","name":"IgIV para la nefropat\u00eda asociada al virus BK (BKVN)","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg","datePublished":"2025-05-06T22:43:18+00:00","dateModified":"2025-05-06T22:46:17+00:00","description":"Aprenda sobre la IgIV para la nefropat\u00eda asociada al virus BK. Los temas incluyen una descripci\u00f3n general de la nefropat\u00eda asociada al virus BK, evidencia cient\u00edfica, c\u00f3mo la IgIV la trata y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg","width":1280,"height":853,"caption":"Doctor with an anatomical model of a human kidney"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-bk-virus-associated-nephropathy-bkvn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"IVIG for BK Virus-Associated Nephropathy (BKVN)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Dr. Robert Hakim, Doctor en Farmacia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"El Dr. Robert Chad Hakim, PharmD, naci\u00f3 y creci\u00f3 en Northridge, California. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Wisconsin-Madison. Lo m\u00e1s gratificante de su trabajo es tomar la iniciativa para impulsar programas cl\u00ednicos que maximicen el impacto en la atenci\u00f3n al paciente. Cuenta con una certificaci\u00f3n del consejo en cuidados cr\u00edticos (BCCCP) y sus \u00e1reas de especializaci\u00f3n son cuidados cr\u00edticos, informaci\u00f3n sobre medicamentos, medicina general y cardiolog\u00eda. En su tiempo libre, disfruta viajando.\u00a0","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"People who have received a kidney transplant often develop a condition called BK virus-associated nephropathy (or BKVN). This is a serious kidney problem that\u2019s caused by the BK virus. If not treated properly, it can contribute to kidney failure or premature graft loss in kidney transplant recipients (a person who received a healthy kidney from&hellip;","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/05\/doctor-model-kidney.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"People who have received a kidney transplant often develop a condition called BK virus-associated nephropathy (or BKVN). This is a serious kidney problem that\u2019s caused by the BK virus. If not treated properly, it can contribute to kidney failure or premature graft loss in kidney transplant recipients (a person who received a healthy kidney from&hellip;","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27415"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27415\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27416"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27415"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}